Back

Meta-analysis of the performances of contemporary risk models in cardiac surgery for infective endocarditis

28 August 2023 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Treatment and prevention of infective endocarditis Surgery ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Tom Kai Ming Wang

Cleveland Clinic, Cleveland (United States of America)

7 More presentations in this session

Presentation thumbnail
Do we need to improve the general oral health of our population to reduce the risk of Infective Endocarditis?
Mr A. Davies De Mugica (London, GB)
Abstract Slides Video
Presentation thumbnail
Factors associated with early and late Staphylococcus aureus bacteraemia after first cardiac implantable electronic device implantation a Danish nationwide cohort study
Doctor K. Bengtsen (Roskilde, DK)
Abstract Slides Video
Presentation thumbnail
Surgery in patients with infective endocarditis and prognostic importance of patient frailty
Mr P. Graversen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
A single centre retrospective analysis of the management and outcomes of cardiac device-related infective endocarditis
Doctor H. Butt (London, GB)
Abstract Slides Video
Presentation thumbnail
Blood cardioplegia may be better than crystalloid cardioplegia during cardiac surgery for infective endocarditis
Mr R. Safarov (Jena, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Treatment and prevention of infective endocarditis

The Event

Event poster

ESC Congress 2023

28 August 2023 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Derivation and validation of novel logistic risk score for infective endocarditis surgery
thumbnail
Congress Presentation
External validation of the EuroSCORE I and II prediction models for postoperative 30-day mortality in patients with infective endocarditis: results from a nationwide prospective registry
thumbnail
Congress Presentation
Predictive models for mortality in cardiogenic shock: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources